Report
Jesse Redmond

The Highlights

The US cannabis MSOS ETF inched 2.89% higher this week, while the global YOLO ETF gained 3.77%. MSOS had $13,308,500 in inflows this week, which interestingly came before the big DEA news on Thursday. On Thursday, the Justice Department officially proposed a new rule to reclassify cannabis from Schedule to Schedule III. The notice of proposed rulemaking sent to the Federal Register on Tuesday stated the Attorney General “concurs with the HHS’ recommendation, for purposes of initiation of these rulemaking proceedings, that marijuana has a potential for abuse less than the drugs or other substances in Schedules I and II.” This kicks off a 60-day comment period. After receiving and assessing comments, officials will analyze the input and make a final determination. Potentially, the intent is to have the final rule in place ahead of the Democratic National Convention, which begins on August 19. This would be consistent with our thinking that we are seeing a coordinated democratic effort to advance cannabis reform ahead of the elections to mobilize and sway younger voters. The President and Vice President both made social media posts promoting the news this week. Cresco (CSE: CL, OTCQX: CRLBF) CEO Charlie Bachtell joined us on Higher Exchanges to discuss politics and the company’s first-quarter results. Bachtell shared his perspective on Schedule III’s next steps, timing, and impact on Cresco’s business. Last year was the year of the core and Bachtell highlighted the tough decisions the company made to cut costs and rationalize the footprint. He told us, “Every year is now the year of the core. It is just who we are.” Those interested can listen on Apple Podcasts, Spotify, or X Spaces. Links are accessible in our full report. Gold Flora (NEO: GRAM, OTCQX: GRAM) reported 1Q24 earnings on Wednesday. Cultivation expansion drove revenue 13.2% higher sequentially, which exceeded our estimate of $29.2 million. Adjusted EBITDA of -$1.8 million missed our estimate of $0.1 million. Higher expenses associated with the expanded cultivation caused the lower AEBITDA. We will revisit our estimates.
Provider
Water Tower Research
Water Tower Research

​Water Tower Research is built on the foundation of democratizing information flow. We bridge the growing information gap between companies and investors through our investor engagement strategies and open-access research platform.

Our research analysts are Wall Street veterans with the experience and knowledge to work with companies and investors in tandem. We provide access to the information and content that anchors the due diligence process for both professional money managers and individual investors. We leverage traditional research distribution channels and the best of modern digital strategies and tactics to amplify this information flow globally to engage all categories of investors and stakeholders.

Information flow is the foundation for creating investor awareness, knowledge, and engagement. Our mission is to help companies and investors have the tools they need and achieve their goals.

Analysts
Jesse Redmond

Other Reports from Water Tower Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch